Syncope - A systematic overview of classification, pathogenesis, diagnosis and management;Synkopen - Eine systematische übersicht zur klassifikation, pathogenese, diagnostik und therapie

Fortschritte der Neurologie Psychiatrie

Volumn 70, Issue 2, 2002, Pages 95-107

  Hilz, M J ^a   Marthol, H ^a   Neundorfer B ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; DESMOPRESSIN; DISOPYRAMIDE; EPHEDRINE; ERYTHROPOIETIN; FLUDROCORTISONE; FLUOXETINE; IBUPROFEN; INDOMETACIN; ISOPRENALINE; METHYLPHENIDATE; METOCLOPRAMIDE; MIDODRINE; MINERALOCORTICOID; OCTREOTIDE; PHENTERMINE; SCOPOLAMINE; SERTRALINE; THEOPHYLLINE; VASOCONSTRICTOR AGENT;

ANEMIA; ANXIETY; ARTICLE; BLOOD PRESSURE; BRAIN PERFUSION; CLINICAL FEATURE; COFFEE; CONSCIOUSNESS DISORDER; COUGHING; DEFECATION; DISEASE CLASSIFICATION; DROWSINESS; EMOTIONAL STRESS; FEAR; HEADACHE; HEART RATE; HUMAN; HYPOTENSION; MICTURITION; ORTHOSTATIC HYPOTENSION; PATHOGENESIS; SNEEZING; SYNCOPE; VERTIGO; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; PROGNOSIS; REVIEW;

DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPOTENSION, ORTHOSTATIC; PROGNOSIS; SYNCOPE;

EID: 0036008048     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-19923     Document Type: Article

References (112)

1. Fainting: Approach to management
2. Cardiac causes of syncope
3. Vasovagal syncope
4. Syncope. Physiological considerations and an analysis of the clinical characteristics in 510 patients
5. Neurally mediated syncope
6. Asystolische anfälle
7. Evaluation and outcome of emergency room patients with transient loss of consciousness
8. Evaluation of prognostic classifications for patients with syncope
9. Evaluation and outcome of patients with syncope
10. A prospective evaluation and follow-up of patients with syncope
11. Prospective evaluation of syncope
12. Syncope
13. Exercise testing in patients with aortic stenosis
14. Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy
15. Valvular aortic stenosis. A clinical and hemodynamic profile of patients
16. Syncope in aortic valvular stenosis
17. Sustained arrhythmias in hypertrophic obstructive cardiomyopathy
18. Syncope in hypertrophic cardiomyopathy
19. The Bezold-Jarisch reflex revisited: Clinical implications of inhibitory reflexes originating in the heart
20. Factors that predict syncope during ventricular tachycardia in patients
21. Hypoglycemia as a possible factor in the induction of vasovagal syncope
22. Psychiatric illnesses in patients with syncope
23. Psychiatric syncope: A new look at an old disease
24. Postural hypotension: Causes, clinical features investigation, and management
25. Neurally mediated syncope and syncope due to autonomic failure: Differences and similarities
26. Postural tachycardia syndrome
27. Twenty-four-hour heart rate power spectrum for evaluation of autonomic dysfunction in Guillain-Barré-syndrome
28. Diagnosis and management of diabetic autonomic neuropathy
29. The sympathetic-nervous-system defect in primary orthostatic hypotension
30. Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine)
31. Atrial natriuretic factor in human autonomic failure
32. Plasma endothelin during upright tilt: Relevance for orthostatic hypotension?
33. Specificity of neural effect on renal tubular sodium reabsorption
34. Role of the sympathetic nervous system in regulating renin and aldosterone production in man
35. Hypotension-induced vasopressin release distinguishes between pure autonomic failure and multiple system atrophy with autonomic failure
36. Effect of recombinant erythropoietin on anemia and orthostatic hypotension in primary autonomic failure
37. Prevalence of orthostatic hypotension in Parkinson's disease
38. Management of orthostatic hypotension
39. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy
40. Orthostatic hypotension in clinical pharmacology
41. Head-up tilt: A useful test for investigating unexplained syncope
42. Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope
43. Isoproterenol induction of vasodepressor-type reaction in vasodepressor-prone persons
44. Cardiac electrophysiologic and hemodynamic correlates of neurally mediated syncope
45. A lecture on vasovagal syncope and the carotid sinus mechanisms: With comments on Gower's and Nothnagel's syndrome
46. Syncopal attacks compulsively self-induced by Valsalva's maneuver associated with typical absence seizures. A case report
47. Glossopharyngeal neuralgia associated with bradycardia, syncope, and seizures
48. An electroencephalographic study of glossopharyngeal neuralgia with syncope
49. Swallowing syncope: Observations in the absence of conduction system or esophageal disease
50. Swallow syncope. Report of a case and review of the literature
51. Deglutition syncope
52. Cardiac asystole in a normal young man following physical effort
53. Asystole following treadmill exercise in a man without organic heart disease
54. Postexertional cardiac asystole in a young man without organic heart disease
55. Asystole after exercise in healthy persons
56. Post-exercise asystolic arrest in a young man without organic heart disease: Utility of head-up tilt testing in guiding therapy
57. Life-threatening, "vagal resection" to physical fitness test
58. Exercise induced vasodepressor syncope
59. Syncope and fainting: Classification and pathophysiological basis
60. Micturition syncope. A reappraisal
61. Syncope: Current diagnosis and treatment
62. Hyperactive carotid sinus reflex and carotid sinus syncope
63. Carotid sinus hypersensitivity and syncope
64. A scientific evaluation of the carotid sinus syndrome
65. Vasovagal reactions may occur after orthotopic heart transplantation
66. Fainting precipitated by collapse-firing of venous baro-receptors
67. Measurement of plasma catecholamine concentrations. An assessment of anxiety
68. Physiologic neuroendocrine arousal by mental arithmetic stress test in healthy subjects
69. Stress response pattern
70. Post haemorrhagic fainting. Study by cardiac output and forearm flow
71. Neurally mediated syncope: Pathogenesis, diagnosis, and treatment
72. Cardiovascular dynamics during orthostasis and the influence of intravascular instrumentation
73. Evaluation of syncope by upright tilt testing with isoproterenol. A nonspecific test
74. Diagnostic accuracy of a low dose isoproterenol head up tilt protocol
75. Value of head-up tilt testing potentiated with sublingual nitroglycerin to assess the origin of unexplained syncope
76. Adenosine: Potential modulator for vasovagal syncope
77. Evaluation of edrophonium as a provocative agent for vasovagal syncope during head-up tilt-table testing
78. Orthostatic tolerance in patients with unexplained syncope
79. Combined head-up tilt and lower body suction: A test of orthostatic tolerance
80. Carotid sinus hypersensitivity and syncope
81. Symptomatic "isolated" carotid sinus hypersensitivity: Natural history and results of treatment with anticholinergic drugs or pacemaker
82. Physical manoeuvres that reduce postural hypotension in autonomic failure
83. Alcohol ingestion lowers supine blood pressure, causes splanchnic vasodilatation and worsens postural hypotension in primary autonomic failure
84. Are portable folding chairs useful to combat orthostatic hypotension?
85. Use of an elastic garment in the treatment of orthostatic hypotension
86. Treatment of orthostatic intolerance with inflatable abdominal band
87. An assessment of various methods of treatment of idiopathic orthostatic hypotension
88. Cardiovascular reflexes and biochemical responses in progressive autonomic failure
89. Cardiac pacing does not improve orthostatic tolerance in patients with vasovagal syncope
90. Cardiac pacing for prevention of recurrent vasovagal syncope
91. Successful treatment of orthostatic hypotension with 9-alpha fluorohydrocortisone
92. Orthostatic hypotension. Treatment with sodium chloride and sodium retaining steroid hormones
93. Mineralocorticoid-induced hypertension in patients with orthostatic hypertension
94. The effect of desmopressin on nocturnal polyuria, overnight weight loss, and morning postural hypotension in patients with autonomic failure
95. Neurogenic orthostatic hypotension: A double-blind, placebo-controlled study with midodrine
96. Differential effect of L-threo-3,4-dihydroxyphenylserine in pure autonomic failure and multiple system atrophy with autonomic failure
97. Could treatment with DOPS do for autonomic failure what DOPA did for Parkinson's disease?
98. The treatment of orthostatic hypotension with dihydroxyphenylserine
99. The treatment of postprandial hypotension in autonomic failure with 3,4-DL-threo-dihydroxyphenylserine
100. The anemia of primary autonomic failure and its reversal with recombinant erythropoietin
101. Treatment of orthostatic hypotension with erythropoietin
102. Recent advances in the treatment of orthostatic hypotension
103. The potent pressor effect of phenylpropanolamine in patients with autonomic impairment
104. Treatment of autonomic neuropathy with a somatostatin analogue SMS-201-995
105. Treatment of orthostatic hypotension with midodrine and octreotide
106. Effects of the peptide release inhibitor, octreotide, on daytime hypotension and on nocturnal hypertension in primary autonomic failure
107. Prevention of glucose-induced hypotension by the somatostatin analogue octreotide (SMS 201-995) in chronic autonomic failure: Haemodynamic and hormonal changes
108. The effects of the somatostatin analogue, octreotide, on postural hypotension, before and after food ingestion, in primary autonomic failure
109. Effect of the somatostatin analogue, octreotide, on exercise-induced hypotension in human subjects with chronic sympathetic failure
110. Evaluation of oral cisapride and metoclopramide in diabetic autonomic neuropathy: An eight week double-blind crossover study
111. Pheripheral dopaminergic blockade for the treatment of diabetic orthostatic hypotension
112. Hemodynamic und humoral effects of caffeine in autonomic failure. Therapeutic implications for postprandial hypotension